Replication deficient recombinant viruses expressing antigens regulated by transcriptional control elements comprising multiple elements

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9163237
APP PUB NO 20140113368A1
SERIAL NO

14096916

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a replication deficient recombinant virus encoding at least one antigen and/or antigenic epitope, wherein expression of said antigen and/or antigenic epitope is regulated by a transcriptional control element comprising at least two elements driving early expression of said antigen and/or antigenic epitope and the use of said replication deficient recombinant virus as medicament or vaccine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAVARIAN NORDIC A/SHEJRESKOVVEJ 10A DK3490 KVISTGAARD DENMARK

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baur, Karen Munich, DE 3 16
Brinkmann, Kay Munich, DE 7 41
Hausmann, Jürgen Gundelfingen, DE 12 22

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 20, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00